Among the 51 823 postmenopausal women in the Swedish Mammography Cohort, we investigated breast cancer risk in relation to the FFQ-based estimated lignan intake by oestrogen receptor (ER) and progesterone receptor (PR) subtypes. A significant 17% risk reduction for breast cancer overall in the high lignan quartile was observed, especially among PMH user (P interaction o0.010), but no heterogeneity across ER/PR subtypes.
Plant lignans, a major type of phytoestrogens in Nordic countries, are mainly present in cereals, fruit, and vegetables (Adlercreutz, 1998a, b) and are metabolised to mammalian lignans (e.g. enterolactone (ENL)) by the intestinal microflora (Adlercreutz, 2002) . Since a preventive action of lignans against breast cancer was suggested (Adlercreutz et al, 1982) , this has been evaluated in vitro (Welshons et al, 1987; Hirano et al, 1990; Mousavi and Adlercreutz, 1992) , in vivo Thompson, 1991, 1992) and in clinical studies (Adlercreutz et al, 1988 (Adlercreutz et al, , 1991 Phipps et al, 1993; Thompson et al, 2005) . Biological plausibility was discussed in a recent review (Adlercreutz, 2007) . Hormone-dependent (Adlercreutz et al, 1992 , 1993 ) and other mechanisms (Hirano et al, 1990; Kitts et al, 1999; Mäkelä et al, 1999; Prasad, 2000; Rickard et al, 2000) have been suggested. Six prospective (den Tonkelaar et al, 2001; Keinan-Boker et al, 2004; Kilkkinen et al, 2004; Olsen et al, 2004; Touillaud et al, 2007; Verheus et al, 2007) and six case -control studies Dai et al, 2002; McCann et al, 2002 McCann et al, , 2004 McCann et al, , 2006 Fink et al, 2007) have evaluated the issue among postmenopausal women. Of these, only four considered oestrogen and progesterone receptor status of tumours (ER/PR) (den Tonkelaar et al, 2001; Olsen et al, 2004; McCann et al, 2006; Touillaud et al, 2007) . We therefore examined the issue in a large population-based cohort study with stratification by family history of breast cancer, level of alcohol intake, body mass index, and use of postmenopausal hormone (PMH).
MATERIALS AND METHODS
The Swedish Mammography Cohort (SMC) was described previously (Wolk et al, 1998; Suzuki et al, 2006) . It was established in 1987 -90 that all women in Västmanland who were born in 1917 -48, and in Uppsala born in 1914 -48, were invited. A total of 66 651 women completed a questionnaire including diet. In 1997, a second questionnaire was sent to all cohort members. We excluded those with missing or incorrect data, with previous cancer (except non-melanoma skin cancer), who were not post-menopausal and who were 70 þ years old at baseline leaving a cohort of 51 823 women. The information on diet was collected through selfadministrated food-frequency questionnaires in 1987 and 1997. Total lignan intake were estimated using published values of following four lignans; secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol (Mazur et al, 1996 (Mazur et al, , 1998a (Mazur et al, ,b, 2000 Adlercreutz and Mazur, 1997; Mazur and Adlercreutz, 1998; Valsta et al, 2003; Milder et al, 2005; Penalvo et al, 2005; Schwartz and Sontag, 2006; Thompson et al, 2006) . Other nutrients were calculated based on the Swedish National Food Administration database (Bergström et al, 1991) . Cereals (60%), vegetables (27%), and fruits (10%) are the main sources of our lignans. Among a random sample of 137 women from the cohort, the correlation between the FFQ-based estimates of lignan intake and serum ENL levels measured by time-resolved fluoroimmunoassay (Adlercreutz et al, 1998) was r ¼ 0.2 (Spearman's rank). Date of breast cancer diagnosis, death, or migration from the study area were identified by linkage of the cohort through the Swedish Registration System. Information about receptor status of breast tumours, measured by an Abbott immunoassay (Pousette et al, 1986) and an immunohistochemical method, was obtained from Uppsala University Hospital and the Regional Oncology Centre. The study was approved by the Regional Ethics Committee at the Uppsala University Hospital and Karolinska Institute. We used time-dependent multivariate Cox proportional hazards regression model to estimate hazard rate ratios and 95% confidence intervals with age as the time scale (Korn et al, 1997) . We subdivided lignan intakes into four categories based on approximate quartiles. Trend tests were conducted by using the median value for each category of lignans as a continuous variable. Heterogeneity in the results between the ER þ PR þ and other subtypes was evaluated using the Wald statistic (Liao, 2004) . P-value for interaction was evaluated by a likelihood ratio test. Analyses were performed by SAS system, version 9.1 (SAS Institute, Cary, NC, USA). Statistical tests were two-sided, and significance levels defined as Po0.05.
RESULTS
Among 51 823 women with an average 8.3-year follow-up, 1284 invasive breast cancer cases were diagnosed, with details of ER/PR status available for 1188 cases. Of these, 716 were ER þ PR þ , 279 ER þ PRÀ, 50 ERÀPR þ , and 143 ERÀPRÀ tumours. Women with high lignan intake tended to be older, have more education and have greater use of PMH (Table 1) .
Overall, we observed a statistically significant inverse association between lignan intake and breast cancer risk (Table 2) . Compared to women in the lowest quartile (o712 mg day À1 ), the multivariable adjusted relative risks (RR) for the highest quartile (X1036 mg day À1 ) were 0.83 (95% confidence interval ¼ 0.70 -0.97; P trend ¼ 0.042) for overall, 0.86 (0.69 -1.08) for ER þ PR þ , 0.77 (0.54 -1.09) for ER þ PRÀ, 0.92(0.56 -1.52) for ERÀPRÀ. There was no evidence for heterogeneity in the results between the ER þ PR þ and other subtypes (all P heterogeneities X0.65).
In the full adjusted analysis stratified by family history of breast cancer, by levels of alcohol intake and by body mass index (o25 or X25 kg/m 2 ), there was no evidence for interaction with lignans in relation to overall risk or of any subtype; all P values for trends were40.60 and all P values for interaction 40.35. We also observed a significant inverse association of lignans with overall risk among PMH ever-users; the multivariable adjusted RR for the highest quartile of intake compared to the lowest was 46% lower (P trend ¼ o0.0001; Table 3 ). In contrast, among PMH never-users, no association was observed (P interaction ¼ 0.01). The observed interaction for PMH use seemed to be confined to ER þ PR þ tumors (P interaction ¼ 0.016). There was no heterogeneity in the results between ER þ PR þ and other tumors (all P heterogeneity X0.21). Lignans were positively correlated with intake of fruits and vegetables (r ¼ 0.4) and of cereal, fruit and vegetable fibre (r ¼ 0.7, 0.2 and 0.4, respectively). After adjusting for these factors, the result for lignans was slightly attenuated but still significant among PMH user (Table 3) .
DISCUSSION
In this large population-based prospective cohort of postmenopausal women, we observed a significant inverse association between lignan intake and overall breast cancer risk, especially among PMH user. There was no evidence of heterogeneity across ER/PR tumours. These results are similar to our previous study with a significant inverse association between cereal fibre and breast cancer risk among PMH users (Suzuki et al, 2008) . The estimated lignan intake was correlated with cereal fibre (r ¼ 0.7) but after adjusting for specific fibres, the association among PMH users was still significant. This inverse association agrees with two previous studies among postmenopausal women (Fink et al, 2007; Touillaud et al, 2007) . Non-significant inverse associations Dai et al, 2002; McCann et al, 2002 McCann et al, , 2004 Keinan-Boker et al, 2004; Olsen et al, 2004; Verheus et al, 2007) and no association ( (Haiman et al, 1999) . Given these findings, an inverse relation of risk with lignans is probable in subgroups of women with high circulating oestrogen level just as discussed with (Glazier and Bowman, 2001 ). The possible biological mechanism is not clear, but in vitro studies also showed that lignan ENL in the presence of oestrogens suppressed the oestrogen-induced proliferation in MCF-7 breast cancer cell (Mousavi and Adlercreutz, 1992) and stimulated the synthesis of sex hormone-binding globulin in liver cells (Adlercreutz et al, 1992) .
The lack of association among overweight women may be due to the relatively high circulating oestrogen levels from PMH use having a stronger effect than the endogenous oestrogens formed in peripheral tissues (Cleland et al, 1985; Jurgens et al, 1992; Hankinson et al, 1998) . Compared to lean women, obese women tend to have a lower prevalence of PMH use (Suzuki et al, 2006) and lower level of plasma ENL (Kilkkinen et al, 2001; Johnsen et al, 2004) . Body fat might attenuate the effect of lignans by suppressing intestinal microflora activity (Nishizawa et al, 1988) , or trapping ENL (Johnsen et al, 2004) .
Our finding for ER þ PR þ tumours among PMH users partly agrees with a prospective study (Touillaud et al, 2007) , though these results were not confined to PMH users. No association was Multivariable Cox proportional harzard models with age as the time-scales were adjusted for height (continuous), body mass index (o18.5, 18.5 -24.9, 25 -29.9 , X30 kg m À2 ), education (o12 years of education, X12 years of education), parity (nulliparous, 1 -2, X3), age at first birth (nulliparous, o26, 26 -30, X31 years), age at menarche (p12, 13, X14 years, missing), age at menopause (o51, X51 years), type of menopause (natural, surgery), use of oral contraceptives (ever, never, missing), use of postmenopausal hormones (ever, never, missing), family history of breast cancer among first-degree relatives (yes/no), history of benign breast disease (yes/no), quintiles of total energy intake, quintiles of energyadjusted total fat intake, and alcohol intake (nondrinkers, o3.4, 3.4 -9.9, X10.0 ethanol g day Two-sided P-values for interaction were calculated based on À2 log likelihood test based on the model. d Multivariable-adjusted RR adjusted for age (the time-scale), height (continuous), education (o12 years of education, X12 years of education), parity (nulliparous, 1 -2, X3), age at first birth (nulliparous, o26, 26 -30, X31 years), age at menarche (p12, 13, X14 years, missing), age at menopause (o51, X51 years), type of menopause (natural, surgery), use of oral contraceptives (ever, never, missing), use of postmenopausal hormones (ever, never, missing), total energy intake (quintiles), energy adjusted total fat intake (quintiles), alcohol intake (nondrinkers, o3.4, 3.4 -9.9, X10.0).
e Multivariable-adjusted model as above further adjusted for consumption of fruits and vegetables (quintiles), energy-adjusted dietary fibre intake (quintile; cereal, fruit, and vegetable fibre independently).
Dietary lignans and postmenopausal breast cancer R Suzuki et al reported in two prospective studies (den Tonkelaar et al, 2001; Olsen et al, 2004 ) and a case -control study (McCann et al, 2006) . Some nutrient misclassification and individual variation in intestinal microflora, as well as the lack of detailed information about PMH use are all relevant. Lignan estimates were not highly correlated with plasma ENL, but the observed correlation was comparable to those reported previously Hedelin et al, 2006) . In prospective cohort design, this misclassification of exposure tends to be nondifferential which may attenuate the observed association toward null. Further studies need to elucidate this issue with taking the circulating level of oestrogens into consideration.
